Bill Text: IA SF2343 | 2011-2012 | 84th General Assembly | Enrolled
Bill Title: A bill for an act making changes to the controlled substance schedules, applying penalties, and including effective date provisions. Various effective dates; see section 11 of bill.
Spectrum: Bipartisan Bill
Status: (Passed) 2012-05-07 - Fiscal note. SCS. [SF2343 Detail]
Download: Iowa-2011-SF2343-Enrolled.html
Senate
File
2343
AN
ACT
MAKING
CHANGES
TO
THE
CONTROLLED
SUBSTANCE
SCHEDULES,
APPLYING
PENALTIES,
AND
INCLUDING
EFFECTIVE
DATE
PROVISIONS.
BE
IT
ENACTED
BY
THE
GENERAL
ASSEMBLY
OF
THE
STATE
OF
IOWA:
DIVISION
I
RECLASSIFICATION
OF
SUBSTANCES
AND
CONTROLLED
SUBSTANCES
Section
1.
Section
124.204,
subsection
9,
Code
Supplement
2011,
is
amended
by
striking
the
subsection.
Sec.
2.
Section
124.206,
subsection
6,
Code
2011,
is
amended
by
adding
the
following
new
paragraph:
NEW
PARAGRAPH
.
c.
Immediate
precursor
to
fentanyl:
4-anilino-N-phenethyl-4-piperidine
(ANPP).
Sec.
3.
Section
124.208,
subsection
6,
Code
2011,
is
amended
by
adding
the
following
new
paragraphs:
NEW
PARAGRAPH
.
bh.
Boldione
(androsta-1,4-diene-3,17-dione).
NEW
PARAGRAPH
.
bi.
Desoxymethyltestosterone
(17[alpha]-methyl-5[alpha]-androst-2-en-17[beta]-ol);
also
known
as
madol.
NEW
PARAGRAPH
.
bj.
19-nor-4,9(10)-androstadienedione
(estra-4,9(10)diene-3,17-dione).
Sec.
4.
Section
124.210,
subsection
3,
Code
2011,
is
amended
by
adding
the
following
new
paragraph:
NEW
PARAGRAPH
.
0e.
Carisoprodol.
Sec.
5.
Section
124.212,
subsection
5,
Code
2011,
is
amended
by
adding
the
following
new
paragraph:
NEW
PARAGRAPH
.
0a.
Ezogabine
[N-[2-amino-4(4-fluorobenzylamino)-phenyl]carbamic
acid
ethyl
Senate
File
2343,
p.
2
ester].
Sec.
6.
Section
124B.2,
subsection
1,
Code
2011,
is
amended
by
adding
the
following
new
paragraph:
NEW
PARAGRAPH
.
aa.
Ergocristine
and
its
salts.
DIVISION
II
SCHEDULE
I
CONTROLLED
SUBSTANCES
Sec.
7.
Section
124.201,
subsection
4,
Code
2011,
is
amended
to
read
as
follows:
4.
If
any
new
substance
is
designated
as
a
controlled
substance
under
federal
law
and
notice
of
the
designation
is
given
to
the
board,
the
board
shall
similarly
designate
as
controlled
the
new
substance
under
this
chapter
after
the
expiration
of
thirty
days
from
publication
in
the
Federal
Register
of
a
final
order
designating
a
new
substance
as
a
controlled
substance,
unless
within
that
thirty-day
period
the
board
objects
to
the
new
designation.
In
that
case
the
board
shall
publish
the
reasons
for
objection
and
afford
all
interested
parties
an
opportunity
to
be
heard.
At
the
conclusion
of
the
hearing
the
board
shall
announce
its
decision.
Upon
publication
of
objection
to
a
new
substance
being
designated
as
a
controlled
substance
under
this
chapter
by
the
board,
control
under
this
chapter
is
stayed
until
the
board
publishes
its
decision.
If
a
substance
is
designated
as
controlled
by
the
board
under
this
paragraph
subsection
the
control
shall
be
temporary
and
if
within
sixty
days
after
the
next
regular
session
of
the
general
assembly
convenes
it
has
not
made
the
corresponding
changes
in
this
chapter
,
the
temporary
designation
of
control
of
the
substance
by
the
board
shall
be
nullified.
Sec.
8.
Section
124.204,
subsection
4,
paragraph
ai,
Code
Supplement
2011,
is
amended
by
striking
the
paragraph
and
inserting
in
lieu
thereof
the
following:
ai.
(1)
Salvia
divinorum.
(2)
Salvinorin
A.
(3)
HU-210.
[(6aR,10aR)-9-(hydroxymethyl)-6,6-
dimethyl-3-(2-methyloctan-2-yl)
6a,7,10,10a-tetrahydrobenzo[c]
chromen-1-ol)].
(4)
HU-211(dexanabinol,
(6aS,10aS)-9-(hydroxymethyl)-6,6-
dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]
chromen-1-ol).
(5)
Unless
specifically
exempted
or
unless
listed
in
another
schedule,
any
material,
compound,
mixture,
or
preparation
which
contains
any
quantity
of
cannabimimetic
Senate
File
2343,
p.
3
agents,
or
which
contains
their
salts,
isomers,
and
salts
of
isomers
whenever
the
existence
of
such
salts,
isomers,
and
salts
of
isomers
is
possible
within
the
specific
chemical
designation.
(a)
The
term
“cannabimimetic
agents”
means
any
substance
that
is
a
cannabinoid
receptor
type
1
(CB1
receptor)
agonist
as
demonstrated
by
binding
studies
and
functional
assays
within
any
of
the
following
structural
classes:
(i)
2-(3-hydroxycyclohexyl)phenol
with
substitution
at
the
5-position
of
the
phenolic
ring
by
alkyl
or
alkenyl,
whether
or
not
substituted
on
the
cyclohexyl
ring
to
any
extent.
(ii)
3-(1-naphthoyl)indole
or
3-(1-naphthylmethane)indole
by
substitution
at
the
nitrogen
atom
of
the
indole
ring,
whether
or
not
further
substituted
on
the
indole
ring
to
any
extent,
whether
or
not
substituted
on
the
naphthoyl
or
naphthyl
ring
to
any
extent.
(iii)
3-(1-naphthoyl)pyrrole
by
substitution
at
the
nitrogen
atom
of
the
pyrrole
ring,
whether
or
not
further
substituted
in
the
pyrrole
ring
to
any
extent,
whether
or
not
substituted
on
the
naphthoyl
ring
to
any
extent.
(iv)
1-(1-naphthylmethylene)indene
by
substitution
of
the
3-position
of
the
indene
ring,
whether
or
not
further
substituted
in
the
indene
ring
to
any
extent,
whether
or
not
substituted
on
the
naphthyl
ring
to
any
extent.
(v)
3-phenylacetylindole
or
3-benzoylindole
by
substitution
at
the
nitrogen
atom
of
the
indole
ring,
whether
or
not
further
substituted
in
the
indole
ring
to
any
extent,
whether
or
not
substituted
on
the
phenyl
ring
to
any
extent.
(b)
Such
terms
include:
(i)
CP
47,497
and
homologues
5-(1,1-dimethylheptyl)-
2-[(1R,3S)-3-hydroxycyclohexl]phenol.
(ii)
JWH-018
and
AM678
1-Pentyl-3-(1-naphthoyl)indole.
(iii)
JWH-073
1-Butyl-3-(1-naphthoyl)indole.
(iv)
JWH-200[1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl]-1-
naphthalenyl-methanone.
(v)
JWH-19
1-hexyl-3-(1-naphthoyl)indole.
(vi)
JWH-81
1-pentyl-3-[1-(4-methoxynaphthoyl)]indole.
(vii)
JWH-122
1-pentyl-3-(4-methyl-1-naphthoyl)indole.
(viii)
JWH-250
1-pentyl-3-
(2-methoxyphenylacetyl)indole.
(ix)
RCS-4
and
SR-19
1-pentyl-3-[(4methoxy)-benzoyl]indole.
(x)
RCS-8
and
SR
18
1-cyclohexylethyl-3-
(2-methoxyphenylacetyl)indole.
Senate
File
2343,
p.
4
(xi)
AM2201
1-(5-fluoropentyl)-3-(1-naphthoyl)indole.
(xii)
JWH-203
1-pentyl-3-(2-chlorophenylacetyl)indole.
(xiii)
JWH-398
1-pentyl-3-(4-chloro-1-naphthoyl)indole.
(xiv)
AM694
1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole.
(xv)
Cannabicyclohexanol
or
CP–47,497
C8-homolog
5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol.
Sec.
9.
Section
124.204,
subsection
6,
Code
Supplement
2011,
is
amended
by
adding
the
following
new
paragraph:
NEW
PARAGRAPH
.
i.
Any
substance,
compound,
mixture
or
preparation
which
contains
any
quantity
of
any
synthetic
cathinone
that
is
not
approved
as
a
pharmaceutical,
including
but
not
limited
to
the
following:
(1)
Mephedrone,
also
known
as
4-methylmethcathinone,(RS)-2-
methylamino-l-(4-methylphenyl)
propan-1-one.
(2)
3,4-methylenedioxypyrovalerone
(MDPV)[(1-(1,3-
Benzodioxol-5-yl)-2-(1-pyrrolidinyl)-
1-pentanone].
(3)
Methylone,
also
known
as
3,4-methylenedioxymethcathinone.
(4)
Naphthylpyrovalerone
(naphyrone).
(5)
4-fluoromethcathinone(flephedrone)
or
a
positional
isomer
of
4-fluoromethcathinone.
(6)
4-methoxymethcathinone
(methedrone;Bk-PMMA).
(7)
Ethcathinone.
(8)
3,4-methylenedioxyethcathinone(ethylone).
(9)
Beta-keto-N-methyl-3,4-benzodioxyolybutanamine
(butylone).
(10)
N,N-dimethylcathinone(metamfepramone).
(11)
Alpha-pyrrolidinopropiophenone
(alpha-PPP).
(12)
4-methoxy-alpha-pyrrolidinopropiophenone
(MOPPP).
(13)
3,4-methylenedioxy-alpha-pyrrolidinopropiophenone
(MDPPP).
(14)
Alpha-pyrrolidinovalerophenone
(alpha-PVP).
(15)
6,7-dihydro-5H-indeno-
(5,6-d)-1,3-dioxol-6-amine)
(MDAI).
(16)
3-fluoromethcathinone.
(17)
4’-Methyl-alpha-pyrrolidinobutiophenone
(MPBP).
(18)
2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine
(2C-E).
(19)
2-(2,5-Dimethoxy-4-methylphenyl)ethanamine
(2C-D).
(20)
2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine
(2C-C).
(21)
2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine
(2C-I).
(22)
2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine
(2C-T-2).
Senate
File
2343,
p.
5
(23)
2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine
(2C-T-4).
(24)
2-(2,5-Dimethoxyphenyl)ethanamine
(2C-H).
(25)
2-(2,5-Dimethoxy-4-nitrophenyl)ethanamine
(2C-N).
(26)
2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine
(2C-P).
Sec.
10.
Section
124.401,
subsection
1,
paragraph
d,
Code
Supplement
2011,
is
amended
to
read
as
follows:
d.
Violation
of
this
subsection
,
with
respect
to
any
other
controlled
substances,
counterfeit
substances,
or
simulated
controlled
substances
classified
in
section
124.204,
subsection
4,
paragraph
“ai”
,
section
124.204,
subsection
6,
paragraph
“i”
,
or
classified
in
schedule
IV
or
V
is
an
aggravated
misdemeanor.
However,
violation
of
this
subsection
involving
fifty
kilograms
or
less
of
marijuana
or
involving
flunitrazepam
is
a
class
“D”
felony.
Sec.
11.
EFFECTIVE
UPON
ENACTMENT.
This
division
of
this
Act,
being
deemed
of
immediate
importance,
takes
effect
upon
enactment.
______________________________
JOHN
P.
KIBBIE
President
of
the
Senate
______________________________
KRAIG
PAULSEN
Speaker
of
the
House
I
hereby
certify
that
this
bill
originated
in
the
Senate
and
is
known
as
Senate
File
2343,
Eighty-fourth
General
Assembly.
______________________________
MICHAEL
E.
MARSHALL
Secretary
of
the
Senate
Approved
_______________,
2012
______________________________
TERRY
E.
BRANSTAD
Governor